Fig. 6
From: Tissue-specific usage of transposable element-derived promoters in mouse development
Contribution of 5′ end TE-derived TSS in tissue-specific gene expression. a Usage of 5′ end TE-derived TSS of 300 genes expressed in at least one tissue (> 0.1 FPKM). b Contribution of 5′ end TE-derived TSS in gene expression at two developmental stages in five mouse tissues. Y-axis: the expression percentage of 5′ end TE-derived transcripts contributed to the total gene’s expression at both E14.5 and P0 stage in each tissue. c Usage of 5′ end TE-derived TSS of 107 genes that used both 5′ end TE-derived and non-TE-derived TSS in five tissues at two developmental stages. The color of each dot represented the expression percentage of 5′ end TE-derived transcripts, and the size indicated the total gene expression values (FPKM). d Assembled transcripts of Tfpi2 genes at the P0 stage in five mouse tissues. Top: Sashimi plot visualization of splicing-junctions from RMER5-derived 1st exon to next exon in intestine, liver, and kidney. Bottom: expression of three assembled Tfpi2 transcripts across five tissues. e Assembled transcripts of Timd2 genes from E11.5 to P0 stages in mouse liver. Top: Sashimi-plot visualization of splicing-junctions from RLTR14-int-derived 1st exon to next exon in all seven developmental stages. Bottom: expression of RLTR14-int-derived Timd2 increased 13-fold across seven developmental stages in mouse liver